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Evidence for Prolonged Neutrophil
Activation in Patients With Unstable Angina
Telomeres are theprotective caps on the ends of chromosomes; cellswith shortenedtelomeres are more likely to undergo apoptosis. Telomerase is the enzyme that
lengthens telomeres. Narducci and colleagues hypothesized that polymorphonuclear
neutrophils (PMN) from patients with unstable angina (UA) would have increased
telomerase activity. This increased activity during UA implies that these PMN are
resistant to apoptosis and thus may be secreting superoxide and other reactive oxygen
species for longer periods of time, which may ultimately lead to plaque rupture.
Polymorphonuclear neutrophils were isolated from both venous blood and coronary
atherosclerotic plaque and then assayed for telomerase activity. As hypothesized,
telomerase activitywas higher in coronary plaquePMNofpatientswithUAandhigher
in PMN from coronary plaque than in peripheral blood. See page 2369.
Page 2376
Heart Failure
Implantable Device Accurately Measures Pulmonary Artery Pressure
TheCardioMEMSheart failure sensor (HFS) is a percutaneously implanted devicefor ambulatory pulmonary artery pressure (PAP) monitoring. The device was
implanted in the pulmonary artery of 12 patients with congestive heart failure who
then underwent serial echocardiographic assessments and traditional Swan-Ganz
catheterization on 2 occasions. There was excellent correlation between all 3 measure-
ments of PAP and no serious adverse reactions. This study confirms that the HFS
provides accurate measurements of PAP; larger trials are planned to confirm its safety
and clinical utility. See page 2375. See figure.
Cardiac Imaging
DSCT Accurate for Heart Rates >65 beats/min
Dual-source computed tomography (DSCT) provides higher temporal resolutionthan previous CT angiography technology, which should reduce the image
degradation found in patients with fast heart rates. Ropers and colleagues evaluated the
influence of heart rate on image quality in 100 patients undergoing DSCT who were
not pre-treated with beta-blockers. Per-segment evaluability was 92% for heart rates
65 beats/min versus 100% for heart rates65 beats/min, although no differences
were found in the accuracy of stenosis detection. This study suggests that the higher
temporal resolution of DSCT obviates the need for heart rates65 beats/min during
CT angiography. See page 2393.
(continued) A-28Cardiomyopathy
Testing for Fabry Disease in Patients With Hypertrophic Cardiomyopathy
Fabry disease (FD) is caused by decreased activity of lysosomal -galactosidase A(-gal), an enzyme that catalyzes the breakdown of globotriaosylceramides (GL-
3). In patients with FD, GL-3 accumulates in lysosomes and may lead to ventricular
hypertrophy. Monserrat and colleagues studied the prevalence of FD in over 500
patients with hypertrophic cardiomyopathy (HCM) using an initial test of serum
activity of -gal and then sequencing the gene in those with low serum activity. Three
percent of theseHCMpatients had low serumactivity, and1%were confirmed tohave
FD. Studies of these patients’ families allowed the diagnosis of 14 carriers, including 5
patients with cardiac disease. An accompanying editorial by Ackerman and Landstrom
cautions that screening all patients with HCM has low yield and would not be
cost-effective, but that targeted screening of patients with a suspicious family history
may be viable. See pages 2399 and 2404.
